Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
Clinical trial NCT00881751 · COMPLETED
Trial details
- NCT number
- NCT00881751
- Sponsor
- Medical University of South Carolina
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2016-05-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.